CBS Evening News Investigative Report Highlights Urgency for PAMTA Passage

I hope every lawmaker on Capitol Hill had a chance to watch CBS Evening News anchor Katie Couric’s two-part investigative series on the risks of using antibiotics as growth promoters in food animals. After viewing both pieces it would be difficult for most people to question the immediate need to pass the Preservation of Antibiotics for Medical Treatment Act (PAMTA). PAMTA would effectively end the practice of administering constant low doses of antibiotics important to human health in food animals in the hopes of reducing the spread of antibiotic-resistant diseases among the general public. As we mentioned Tuesday, the first installment of the series highlighted the connections between industrial food animal production and the growing number of antibiotic resistant infections across the country. Couric’s second installment dismantled several arguments which critics of PAMTA often use to dissuade passage. I’ll point out just two.

First, the report puts to rest the deceptive claims by PAMTA opponents who point to outdated data from Denmark that they say proves an antibiotic-ban in the U.S. would hurt farmers. Opponents allude that the Danish ban on non-therapeutic antibiotics in food animals was a failure, claiming the numbers show the ban increased the mortality of piglets and required the increase of therapeutic antibiotic usage to treat sick pigs. Couric’s second report opened in Denmark, focusing on the “Danish Experience.” Farmers and researchers there tell a much different story. Couric interviewed Danish hog farmer Soren Helmer, who said, “We thought we could not produce pigs as efficient as we did before. But that was proven wrong.” Couric reported, “since the ban the Danish pork industry has grown by 43 percent making it one of the top exporters in the world.”

As I pointed out in an earlier blog post, Danish scientists, from the National Food Institute at the Technical University of Denmark, Drs. Frank Møller Aarestrup and Henrik Wegener, submitted last July written testimony for a U.S. House Committees Rules hearing on PAMTA. They wrote, “As you may be aware, representatives of organizations funded by U.S. agri-business have criticized and mis-represented the facts on the Danish ban of antibiotics since its inception.” The scientists found that the total antibiotic use for pork decreased by 50% and that piglet deaths initially increased, but after improving animal living conditions those numbers have since dipped below pre-ban numbers. Read More >

Ban On Arsenicals Is Common Sense

Today’s announcement by U.S. Rep. Steve Israel (D-NY) introducing legislation to ban the use of the arsenical compound roxarsone once again shines the spotlight on the all-too common practice of the unnecessary use of antimicrobial drugs in industrial animal production.

“American consumers simply shouldn’t have to ingest this arsenic compound when they sit at the kitchen table,” said Rep. Israel.  “There’s a reason some major poultry producers have stopped using it – it can only cause environmental and health problems. With cancer levels on the rise we need to be vigilant about the sources of health problems, and that means banning roxarsone.”

The bill (H.R. 3624), known as the “Poison-Free Poultry Act of 2009,” would prohibit all uses of roxarsone as a food additive in animals.

What is roxarsone and why should we be concerned about its use?  Roxarsone is an arsenical antimicrobial drug used extensively in poultry and swine production to combat intestinal parasites, speed growth and improve pigmentation. Some large poultry integrators have reported voluntarily withdrawing roxarsone from feed regimens, although I am unaware of efforts to validate these claims. Further, I am unaware of similar voluntary withdrawals from swine producers. Federal agencies do not mandate the reporting of food animal drug usage, making it difficult to characterize the use of the drug in food animal production. Read More >

Public Health & Industrial Farm Animal Production: Setting the Record Straight

The American Veterinary Medical Association’s recent “response” to the Pew Commission on Industrial Farm Animal Production’s final report on the state of industrial animal agriculture is disconcerting. It appears that leadership of the veterinary professional organization is attempting to misuse science to obfuscate and delay critically needed changes in the food animal production system rather than tackling very real public health and environmental threats head on.

PCIFAP public meeting in North Carolina, 4/10/07

PCIFAP public meeting in North Carolina, 4/10/07

For years a groundswell had been building from a widespread group of experts and advocates in the areas of public health, environment, social justice, and animal welfare sounding the alarms about the serious problems industrial food animal production poses. But until the Pew Commission on Industrial Farm Animal Production (PCIFAP) decided to take on the politically controversial issue, there had never been a comprehensive examination of industry’s practices by such a respected and diverse panel of experts. Following a grueling 2½ -year discovery process, and despite several overt attempts by industry to discredit it, the Commission concluded that the scientific evidence was too strong and the public health risk too great to ignore and offered a series of consensus recommendations on how to repair our unsafe food animal production system.

The tone and timing of the AVMA’s 38-page response to the PCIFAP final report, 15 months after it was released, is quite telling. The document’s executive summary starts out by suggesting that the PCIFAP’s technical reports (published separately) were “biased,” and that, “the Pew report contains significant flaws and major deviations from both science and reality.” Another telling facet is that the “response” contains very little scientific citation to backup its rebuttal. It’s not a coincidence that this response coincides with the recent revelation that the Obama Administration supports the idea of banning the use of key antibiotics as growth promoters in food animals, which happens to be one of the PCIFAP’s key recommendations. Not to mention, this year’s version of the Preservation of Antibiotics for Medical Treatment Act (PAMTA) appears to have a much better chance of passing than in any prior year.

Read More >